Afzal Misrani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Afzal Misrani has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Cheng Long
School of Life Sciences, South China Normal University, Guangzhou, Guangdong Province, China
6 shared publications Sidra Tabassum
School of Life Sciences, South China Normal University, Guangzhou, 510631, PR China
4 shared publications- Li Yang
School of Life Sciences, Guangzhou University, Guangzhou, Guangdong Province, China
3 shared publications Bin-Liang Tang
School of Life Sciences, South China Normal University, Guangzhou, 510631, PR China
1 shared publication- Chan Li
School of Life Sciences, Guangzhou University, Guangzhou 510006, China
1 shared publication - Conelius Ngwa
Department of Neurology The University of Texas Health Science Center at Houston, McGovern Medical School Houston Texas USA
1 shared publication
Latest Publications
- Open Access
Microglial Transmembrane 119 (Tmem119) is Protective in Ischemic Stroke
Microglial responses to cerebral ischemia are tightly regulated by inhibitory pathways that limit excessive post‐stroke inflammation. Transmembrane protein 119 (Tmem119) has emerged as an important regulator of microglial activation and neuroinflammatory signaling. We investigated the role of microglial Tmem119 during acute ischemic stroke using primary microglia and a young adult mouse model. Primary microglia were transfected with Tmem119‐siRNA and subjected to oxygen–glucose deprivation (OGD) alone or combined with lipopolysaccharide (LPS) stimulation. In vivo, young adult male mice received stereotaxic injection of lenti‐Tmem119 or lenti‐GFP for 4 weeks before 60 min of transient middle cerebral artery occlusion (MCAO). Tmem119 expression and inflammatory responses were assessed by qPCR, Western blotting, and ELISA at 1 and 3 days after stroke. Infarct volume and neurobehavioral outcomes were also evaluated. Tmem119 silencing significantly increased IRAK4, IRF5, and CD68 mRNA expression in primary microglia. Ischemic injury reduced microglial Tmem119 protein expression and increased IRAK4 signaling in vivo. In contrast, lenti‐Tmem119 treatment before MCAO decreased phosphorylated IRAK4 protein expression and increased IL‐10 levels in both plasma and ischemic brain tissue compared with lenti‐GFP controls. Tmem119 overexpression also significantly reduced infarct volume and improved neurobehavioral outcomes. These findings demonstrate that microglial Tmem119 exerts a protective anti‐inflammatory role during the acute phase of ischemic stroke by suppressing IRAK4‐mediated inflammatory signaling and enhancing IL‐10 production. Collectively, Tmem119 limits microglial activation, reduces ischemic brain injury, and improves functional recovery, identifying Tmem119 as a promising therapeutic target for ischemic stroke.
Open AccessMicroglial Transmembrane 119 (Tmem119) is Protective in Ischemic Stroke
Microglial responses to cerebral ischemia are tightly regulated by inhibitory pathways that limit excessive post‐stroke inflammation. Transmembrane protein 119 (Tmem119) has emerged as an important regulator of microglial activation and neuroinflammatory signaling. We investigated the role of microglial Tmem119 during acute ischemic stroke using primary microglia and a young adult mouse model. Primary microglia were transfected with Tmem119‐siRNA and subjected to oxygen–glucose deprivation (OGD) alone or combined with lipopolysaccharide (LPS) stimulation. In vivo, young adult male mice received stereotaxic injection of lenti‐Tmem119 or lenti‐GFP for 4 weeks before 60 min of transient middle cerebral artery occlusion (MCAO). Tmem119 expression and inflammatory responses were assessed by qPCR, Western blotting, and ELISA at 1 and 3 days after stroke. Infarct volume and neurobehavioral outcomes were also evaluated. Tmem119 silencing significantly increased IRAK4, IRF5, and CD68 mRNA expression in primary microglia. Ischemic injury reduced microglial Tmem119 protein expression and increased IRAK4 signaling in vivo. In contrast, lenti‐Tmem119 treatment before MCAO decreased phosphorylated IRAK4 protein expression and increased IL‐10 levels in both plasma and ischemic brain tissue compared with lenti‐GFP controls. Tmem119 overexpression also significantly reduced infarct volume and improved neurobehavioral outcomes. These findings demonstrate that microglial Tmem119 exerts a protective anti‐inflammatory role during the acute phase of ischemic stroke by suppressing IRAK4‐mediated inflammatory signaling and enhancing IL‐10 production. Collectively, Tmem119 limits microglial activation, reduces ischemic brain injury, and improves functional recovery, identifying Tmem119 as a promising therapeutic target for ischemic stroke.
- Open Access
- 24 October 2026
- Published by Wolters Kluwer Health in Neural Regeneration Research
Synchronization of the nucleus accumbens-ventral hippocampus reflects cooperative ability and predicts social dysfunction after training in mice
Cooperation is a fundamental form of social behavior that promotes collective benefits and group survival. Although considerable progress has been made in understanding cooperation from behavioral and theoretical perspectives, the neural activities underlying cooperative behavior remain incompletely understood. In the present study, we established a cooperative behavioral paradigm in pairs of mice using a Skinner box, with the protocol spanning 22 days. Mice were retrospectively classified into high-, middle-, and low-performance groups based on their performance in the cooperation task. In vivo local field potential recordings from the nucleus accumbens and ventral hippocampus were then conducted in the three groups. High-cooperation mice showed significantly increased delta and low-gamma power in the nucleus accumbens, as well as enhanced delta, theta, beta, and low-gamma power in the ventral hippocampus, compared to low-cooperation mice. Meanwhile, nucleus accumbens–ventral hippocampus coherence within the beta and low-gamma frequency bands was significantly reduced in high-cooperation animals. Behaviorally, high-cooperation mice exhibited social dysfunction as shown by reduced social interaction and more pronounced anxiety-like behaviors compared with low-cooperation mice after training. Collectively, these findings provide early evidence that individual differences in cooperative behavior are associated with distinct patterns of neural oscillatory activity within the nucleus accumbens–ventral hippocampus circuit. Moreover, enhanced cooperative performance was correlated with alterations in social and affective behavior, such as increased social avoidance and anxiety-like behavior. The results suggest that nucleus accumbens–ventral hippocampus oscillatory dynamics may represent a neural correlate of cooperative behavior, and that training-induced differences in cooperative performance are associated with subsequent changes in social and affective functioning.
- 24 October 2026
- Published by Wolters Kluwer Health in Neural Regeneration Research
Open AccessSynchronization of the nucleus accumbens-ventral hippocampus reflects cooperative ability and predicts social dysfunction after training in mice
Cooperation is a fundamental form of social behavior that promotes collective benefits and group survival. Although considerable progress has been made in understanding cooperation from behavioral and theoretical perspectives, the neural activities underlying cooperative behavior remain incompletely understood. In the present study, we established a cooperative behavioral paradigm in pairs of mice using a Skinner box, with the protocol spanning 22 days. Mice were retrospectively classified into high-, middle-, and low-performance groups based on their performance in the cooperation task. In vivo local field potential recordings from the nucleus accumbens and ventral hippocampus were then conducted in the three groups. High-cooperation mice showed significantly increased delta and low-gamma power in the nucleus accumbens, as well as enhanced delta, theta, beta, and low-gamma power in the ventral hippocampus, compared to low-cooperation mice. Meanwhile, nucleus accumbens–ventral hippocampus coherence within the beta and low-gamma frequency bands was significantly reduced in high-cooperation animals. Behaviorally, high-cooperation mice exhibited social dysfunction as shown by reduced social interaction and more pronounced anxiety-like behaviors compared with low-cooperation mice after training. Collectively, these findings provide early evidence that individual differences in cooperative behavior are associated with distinct patterns of neural oscillatory activity within the nucleus accumbens–ventral hippocampus circuit. Moreover, enhanced cooperative performance was correlated with alterations in social and affective behavior, such as increased social avoidance and anxiety-like behavior. The results suggest that nucleus accumbens–ventral hippocampus oscillatory dynamics may represent a neural correlate of cooperative behavior, and that training-induced differences in cooperative performance are associated with subsequent changes in social and affective functioning.
- Open Access
- 22 September 2023
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 19 (6) , 1351-1359
Vibration-reduced anxiety-like behavior relies on ameliorating abnormalities of the somatosensory cortex and medial prefrontal cortex
JOURNAL/nrgr/04.03/01300535-202406000-00040/inline-graphic1/v/2025-09-25T172020Z/r/image-tiff Tibetan singing bowls emit low-frequency sounds and produce perceptible harmonic tones and vibrations through manual tapping. The sounds the singing bowls produce have been shown to enhance relaxation and reduce anxiety. However, the underlying mechanism remains unclear. In this study, we used chronic restraint stress or sleep deprivation to establish mouse models of anxiety that exhibit anxiety-like behaviors. We then supplied treatment with singing bowls in a bottomless cage placed on the top of a cushion. We found that unlike in humans, the combination of harmonic tones and vibrations did not improve anxiety-like behaviors in mice, while individual vibration components did. Additionally, the vibration of singing bowls increased the level of N-methyl-D-aspartate receptor 1 in the somatosensory cortex and prefrontal cortex of the mice, decreased the level of γ-aminobutyric acid A (GABA) receptor α 1 subtype, reduced the level of CaMKII in the prefrontal cortex, and increased the number of GABAergic interneurons. At the same time, electrophysiological tests showed that the vibration of singing bowls significantly reduced the abnormal low-frequency gamma oscillation peak frequency in the medial prefrontal cortex caused by stress restraint pressure and sleep deprivation. Results from this study indicate that the vibration of singing bowls can alleviate anxiety-like behaviors by reducing abnormal molecular and electrophysiological events in somatosensory and medial prefrontal cortex.
- 22 September 2023
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 19 (6) , 1351-1359
Open AccessVibration-reduced anxiety-like behavior relies on ameliorating abnormalities of the somatosensory cortex and medial prefrontal cortex
JOURNAL/nrgr/04.03/01300535-202406000-00040/inline-graphic1/v/2025-09-25T172020Z/r/image-tiff Tibetan singing bowls emit low-frequency sounds and produce perceptible harmonic tones and vibrations through manual tapping. The sounds the singing bowls produce have been shown to enhance relaxation and reduce anxiety. However, the underlying mechanism remains unclear. In this study, we used chronic restraint stress or sleep deprivation to establish mouse models of anxiety that exhibit anxiety-like behaviors. We then supplied treatment with singing bowls in a bottomless cage placed on the top of a cushion. We found that unlike in humans, the combination of harmonic tones and vibrations did not improve anxiety-like behaviors in mice, while individual vibration components did. Additionally, the vibration of singing bowls increased the level of N-methyl-D-aspartate receptor 1 in the somatosensory cortex and prefrontal cortex of the mice, decreased the level of γ-aminobutyric acid A (GABA) receptor α 1 subtype, reduced the level of CaMKII in the prefrontal cortex, and increased the number of GABAergic interneurons. At the same time, electrophysiological tests showed that the vibration of singing bowls significantly reduced the abnormal low-frequency gamma oscillation peak frequency in the medial prefrontal cortex caused by stress restraint pressure and sleep deprivation. Results from this study indicate that the vibration of singing bowls can alleviate anxiety-like behaviors by reducing abnormal molecular and electrophysiological events in somatosensory and medial prefrontal cortex.
- Open Access
- 14 March 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 4512
Jujuboside A prevents sleep loss-induced disturbance of hippocampal neuronal excitability and memory impairment in young APP/PS1 mice
Sleep deprivation (SD) is the hallmark of modern society and may increase risk of Alzheimer’s disease (AD). However, it is unclear how SD facilitates early cognitive impairments observed in AD models, as the underlying molecular mechanism is largely unknown. Here, we aim to investigate SD-induced cellular and molecular alterations in hippocampus of young APP/PS1 mice and whether jujuboside A (JuA) treatment could negate these alterations. Our results reveal that although SD causes spatial memory impairments in both genotypes, SD decreases frequency and amplitude of mEPSCs and pCREB levels in WT, but increases frequency and amplitude of mEPSCs, NMDAR, GluR1, pCaMKII (β, α) and decreases CREB levels in APP/PS1 mice, implicating that SD may facilitate abnormalities in young APP/PS1 mice via enhancing neuronal excitability. Moreover, JuA suppresses SD-induced enhancement of mEPSCs and prevents memory impairment in APP/PS1 mice. Further, whole-cell puff experiment suggests that JuA may function to activate GABAergic inhibition to reduce SD-induced enhancement of excitatory synaptic transmission in APP/PS1 mice. The present study reveals that sleep loss induces spatial memory impairment in an AD mouse model by disrupting the excitatory signaling pathway, and JuA prevents this via GABAergic mechanism.
- 14 March 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 4512
Open AccessJujuboside A prevents sleep loss-induced disturbance of hippocampal neuronal excitability and memory impairment in young APP/PS1 mice
Sleep deprivation (SD) is the hallmark of modern society and may increase risk of Alzheimer’s disease (AD). However, it is unclear how SD facilitates early cognitive impairments observed in AD models, as the underlying molecular mechanism is largely unknown. Here, we aim to investigate SD-induced cellular and molecular alterations in hippocampus of young APP/PS1 mice and whether jujuboside A (JuA) treatment could negate these alterations. Our results reveal that although SD causes spatial memory impairments in both genotypes, SD decreases frequency and amplitude of mEPSCs and pCREB levels in WT, but increases frequency and amplitude of mEPSCs, NMDAR, GluR1, pCaMKII (β, α) and decreases CREB levels in APP/PS1 mice, implicating that SD may facilitate abnormalities in young APP/PS1 mice via enhancing neuronal excitability. Moreover, JuA suppresses SD-induced enhancement of mEPSCs and prevents memory impairment in APP/PS1 mice. Further, whole-cell puff experiment suggests that JuA may function to activate GABAergic inhibition to reduce SD-induced enhancement of excitatory synaptic transmission in APP/PS1 mice. The present study reveals that sleep loss induces spatial memory impairment in an AD mouse model by disrupting the excitatory signaling pathway, and JuA prevents this via GABAergic mechanism.
- 1 January 2019
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 88, 102-111
Differential effects of citalopram on sleep-deprivation-induced depressive-like behavior and memory impairments in mice
- 1 January 2019
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 88, 102-111
Differential effects of citalopram on sleep-deprivation-induced depressive-like behavior and memory impairments in mice
- 29 May 2017
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 123,p. e55489
Recording EEG in Freely Moving Neonatal Rats Using a Novel Method
Here, we introduce a novel technique designed to record electroencephalography (EEG) in freely moving neonatal epileptic pups and...
- 29 May 2017
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 123,p. e55489
Recording EEG in Freely Moving Neonatal Rats Using a Novel Method
Here, we introduce a novel technique designed to record electroencephalography (EEG) in freely moving neonatal epileptic pups and...
- 25 April 2017
- Vol. 69 (2) , 196-206
Oxytocin system in neuropsychiatric disorders: Old concept, new insights.
Oxytocin (OXT) is a neuropeptide that plays a pivotal role among species peripherally and centrally. It recently has attracted much attention for its involvement in anxiety-related behavior, stress regulation, social behavior and various neuropsychiatric disorders. OXT is one of the important mediators of emotional and social behaviors such as maternal behavior, fear extinction, social support, happiness, and trust. It is also involved in learning and memory process. The recent progresses in OXT system have put this neuropeptide as an important psychotherapeutic intervention for various psychiatric disorders such as stress, anxiety disorders, social phobia, postpartum depression, bipolar disorder, autism, and schizophrenia. In this review, we highlight OXT's contributions to various physiological functions and psychological disorders and discuss its potential use as a therapeutic agent.
- 25 April 2017
- Vol. 69 (2) , 196-206
Oxytocin system in neuropsychiatric disorders: Old concept, new insights.
Oxytocin (OXT) is a neuropeptide that plays a pivotal role among species peripherally and centrally. It recently has attracted much attention for its involvement in anxiety-related behavior, stress regulation, social behavior and various neuropsychiatric disorders. OXT is one of the important mediators of emotional and social behaviors such as maternal behavior, fear extinction, social support, happiness, and trust. It is also involved in learning and memory process. The recent progresses in OXT system have put this neuropeptide as an important psychotherapeutic intervention for various psychiatric disorders such as stress, anxiety disorders, social phobia, postpartum depression, bipolar disorder, autism, and schizophrenia. In this review, we highlight OXT's contributions to various physiological functions and psychological disorders and discuss its potential use as a therapeutic agent.